Shandong Buchang Pharmaceuticals (603858.SS) Earnings Analysis
Shandong Buchang Pharmaceuticals (603858.SS) has no confirmed upcoming earnings date. Trailing P/E 45.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603858.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603858.SS. This page updates as the calendar is published.
603858.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.2282 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.3023 CNY | n/a | n/a | n/a |
| 2025-04-25 | -0.81669 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.2899 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.076 CNY | n/a | n/a | n/a |
603858.SS valuation and analyst view
| Trailing P/E | 45.14 |
|---|---|
| Trailing EPS | 0.35537 CNY |
| Price / book | 1.63 |
| Dividend yield | 2.47% |
| Market cap | 16.87B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shandong Buchang Pharmaceuticals (603858.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603858.SS. This page updates as the calendar is published.
Did 603858.SS beat earnings last quarter?
Consensus estimate data was not available for 603858.SS's 2025-09-29 report.
What is 603858.SS's current P/E ratio and EPS?
603858.SS trades at a trailing P/E of 45.14 on trailing EPS of 0.3553658199409067 CNY.
What do analysts rate 603858.SS?
603858.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.